Frank Tally endowed infectious diseases fellowship + fellows at Tufts Medical Center
The Division of Geographic Medicine and Infectious Diseases at Tufts Medical Center is proud to honor the legacy of Dr. Francis (Frank) P. Tally through an endowed fellowship named in his memory.
The Tally Fellowship allows us to recruit some of the world’s most talented young physician-researchers who share Dr. Tally’s passion for revolutionizing the treatment of devastating infectious diseases.
Dr. Frank Tally was a visionary leader in infectious diseases research and treatment. From 1975 to 1986, he served as a physician, researcher and professor at Tufts Medical Center and Tufts University School of Medicine. He was internationally recognized for his work on bacterial drug resistance. Later, Dr. Tally led teams at Lederle Laboratories, Wyeth Pharmaceuticals and Cubist Pharmaceuticals in developing four major intravenous antibiotics.
As Chief Scientific Officer at Cubist, Dr. Tally co-invented a key patent that led to the development of Cubicin® (daptomycin for injection), a revolutionary antibiotic used to treat bloodstream and heart infections, particularly those caused by methicillin-resistant Staphylococcus aureus (MRSA).
Following his passing in 2006, Dr. Tally’s family and colleagues at Cubist established the Dr. Francis P. Tally Endowed Fellowship in Infectious Diseases at Tufts Medical Center. With generous support from his wife Barbara, children Kevin, Michaela and Patrick, as well as Cubist’s leadership and friends, a $1.25 million endowment was created to ensure future physicians can carry forward Dr. Tally’s commitment to advancing therapies that impact millions worldwide.
Since its inauguration in October 2011, Tally Fellows have included:
- Eavan Muldoon, MD
- Masako Mizusawa, MD
- Bradley Gardiner, MBBS
- Paul Adjei, MBBS
- Jessica Penney, MD, MPH
- Majd Alsoubani, MD
